HOME >> BIOLOGY >> NEWS
Biotech cotton provides same yield with fewer pesticides

Arizona farmers receive the same yield/acre, use fewer chemical insecticides and maintain insect biodiversity when they plant the biotech cotton known as Bt cotton, according to new research.

The finding comes from the first large-scale study that simultaneously examined how growing Bt cotton affects yield, pesticide use and biodiversity.

It's good news for the environment.

"What we see is that it's positive here in Arizona -- no doubt about it," said Yves Carrire, an associate professor of entomology at The University of Arizona in Tucson. "We've reduced pesticide use in Arizona. We've wanted to do that for 25 years."

Bt cotton has been genetically altered to produce Bt toxin, a naturally occurring insecticide that kills pink bollworm, a major pest of cotton. Bt cotton has been planted in Arizona since 1996. Now more than half of the state's 256,000 acres of cotton fields are planted with the biotech plants.

Some have suggested that, in addition to killing the target pests, insecticide-containing crops like Bt cotton would also kill beneficial and non-target arthropods.

The new study found that Bt cotton, also known as transgenic cotton, does not affect the biodiversity of insects in cotton fields.

Carrire said, "There were lots of factors that affected biodiversity in this study. Transgenics were not one of them."

He and his colleagues based their findings on a two-year study of 81 commercial cotton fields in a region of Arizona that spans about 2,500 square miles (6,600 square kilometers). Much of the field and lab work was done by Manda G. Cattaneo as part of her master's research at UA. Cattaneo is now an extension entomologist at Texas A&M University in College Station.

The multidisciplinary team will publish their research in an upcoming issue of the Proceedings of the National Academy of Sciences. A complete list of authors is at the end of this release. The Environmental Prote
'"/>

Contact: Mari N. Jensen
mnjensen@email.arizona.edu
520-626-9635
University of Arizona
1-May-2006


Page: 1 2 3

Related biology news :

1. Biotech breakthrough could end biodiesels glycerin glut
2. How the Biotech Revolution Is Changing the Way We Fight Disease
3. Rutgers: GM/GMO/Biotech crop containment strategy
4. Ronald Cape to receive 2007 Biotechnology Heritage Award
5. Oncolytics Biotech Inc., research collaborators demonstrate reovirus/gemcitabine
6. Oncolytics Biotech Inc. proceeds to initiate US Phase II sarcoma clinical trial
7. Biotechnology Study Center honors Joan V. Ruderman, Salvador Moncada and Charles N. Serhan
8. European Federation of Biotechnology and Elsevier announce launch of biotechnology journal
9. Advances in Optics for Biotechnology, Medicine and Surgery
10. Biolex reports potential for more potent, efficacious antibodies in Nature Biotechnology
11. Developing uses for sugar-cane bagasse: Biotechnology applied to the paper industry

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Biotech cotton provides same yield with fewer pesticides

(Date:2/5/2015)... , Jan. 26, 2015   Epic Sciences , a ... today announced that Murali Prahalad , Ph.D., president and ... World Conference (PMWC) 2015: Silicon Valley, which is taking ... View, Calif. on January 26-28, 2015. ... of Age as Biomarkers." Last year, Epic Sciences was a ...
(Date:2/5/2015)... 2015 New Market Research Reports ... Forecasts To 2020 has Been Added to GrandViewReseach.com Report ... expected to reach USD 5.10 billion by 2020, according ... IR cameras help identify the site of tissue damage ... surging demand in medical imaging applications. They have been ...
(Date:2/5/2015)... 30, 2015  It is gratifying to see that ... for genomic science as a means to better understand ... treatment.  I was honored to participate in today,s White ... program. Since the 1980s my teams ... the first sequenced genome of a free living organism, ...
Breaking Biology News(10 mins):Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 Cytokinetics, ... forces on February 28 with patients and health care ... awareness for Rare Disease Day®. Rare Disease Day ... and calling attention to the special challenges faced by ... them. , “Cytokinetics is proud to stand alongside patients ...
(Date:2/26/2015)... , Feb. 26, 2015 S&P Capital ... Factual Stock Report coverage on MabVax Therapeutics Holdings Inc ... is a clinical stage biotechnology company focused on the ... medical needs in the treatment of cancer. MabVax has ... on the protective immune responses generated by patients who ...
(Date:2/26/2015)... SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; ... commercializes proprietary technologies and products for advanced microarray diagnostics, ... fiscal first quarter ended December  31, 2014. All figures ... unless otherwise stated. "During the quarter ... existing customers and add to our sales pipeline," said ...
(Date:2/26/2015)... Feb. 26, 2015 Protiviti ( www.protiviti.com ), ... of the Governance Portal , designed to increase ... compliance (GRC) tasks across multiple business units and projects. ... help customers better align their controls with the COSO ... ) requirements. In response to client feedback, Protiviti has ...
Breaking Biology Technology:Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3
Cached News: